pharmecort 0.1% cream
pharmex s.a. (0000008077) 132 kifissou ave., peristeri, 12131 - mometasone furoate - cream - 0.1% - mometasone furoate (8000001488) 1mg
enerzair breezhaler (114+46+136)mcg/dose [(150+50+160) mcg/cap] κονισ για εισπνοη (σκληρο καψακιο)
novartis europharm limited, ireland (0000013045) vista building, elm park, merrion road, dublin 4, - - indacaterol; glycopyrronium bromide; mometasone furoate - ΚΟΝΙΣ ΓΙΑ ΕΙΣΠΝΟΗ (ΣΚΛΗΡΟ ΚΑΨΑΚΙΟ) - (114+46+136)mcg/dose [(150+50+160) mcg/cap] - 0031275063 indacaterol 114.000000 mcg; 0000596510 glycopyrronium bromide 58.000000 mcg; 0083919237 mometasone furoate 136.000000 mcg - indacaterol, glycopyrronium bromide and mometasonerifamycin
bioelementa 0,1% cream
dekaz Ε.Π.Ε. - mometasone - ΚΡΕΜΑ - 0,1% - ΦΑΡΜΑΚΕΥΤΙΚΟ ΠΡΟΪΟΝ
posatex
intervet international bv - ορβιφλοξακίνη, mometasone furoate, posaconazole - Οτολογικά - Σκύλοι - Θεραπεία οξείας εξωτερικής ωτίτιδας και οξείας εξάρσεις της υποτροπιάζουσας εξωτερικής ωτίτιδας, που σχετίζονται με βακτήρια ευαίσθητα στη ορβιφλοξακίνη και μύκητες ευαίσθητους στην ποσακοναζόλη, malassezia pachydermatis.
enerzair breezhaler
novartis europharm limited - indacaterol, glycopyrronium bromide, mometasone - Ασθμα - Φάρμακα αποφρακτικών παθήσεων των αναπνευστικών οδών, - enerzair breezhaler is indicated as a maintenance treatment of asthma in adult patients not adequately controlled with a maintenance combination of a long acting beta2 agonist and a high dose of an inhaled corticosteroid who experienced one or more asthma exacerbations in the previous year.
bemrist breezhaler
novartis europharm limited - indacaterol, mometasone furoate - Ασθμα - Φάρμακα αποφρακτικών παθήσεων των αναπνευστικών οδών, - bemrist breezhaler is indicated as a maintenance treatment of asthma in adults and adolescents 12 years of age and older not adequately controlled with inhaled corticosteroids and inhaled short acting beta2-agonists.
atectura breezhaler
novartis europharm limited - indacaterol acetate, mometasone furoate - Ασθμα - Φάρμακα αποφρακτικών παθήσεων των αναπνευστικών οδών, - atectura breezhaler is indicated as a maintenance treatment of asthma in adults and adolescents 12 years of age and older not adequately controlled with inhaled corticosteroids and inhaled short acting beta2-agonists.
zimbus breezhaler
novartis europharm limited - glycopyrronium bromide, indacaterol (acetate), mometasone furoate - Ασθμα - Φάρμακα αποφρακτικών παθήσεων των αναπνευστικών οδών, - maintenance treatment of asthma in adults whose disease is not adequately controlled.
prospiril twisthaler 200mc/dose pd.inh.md
schering plough Α.Φ.Β.Ε.Ε. - mometasone - ΚΟΝΙΣ ΓΙΑ ΕΙΣΠΝΟΗ - 200mc/dose - ΦΑΡΜΑΚΕΥΤΙΚΟ ΠΡΟΪΟΝ
prospiril twisthaler 400mc/dose pd.inh.md
schering plough Α.Φ.Β.Ε.Ε. - mometasone - ΚΟΝΙΣ ΓΙΑ ΕΙΣΠΝΟΗ - 400mc/dose - ΦΑΡΜΑΚΕΥΤΙΚΟ ΠΡΟΪΟΝ